سعر دنروسيف 125 مجم/5 مل معلق 60 مل 2026

Egyptian cefdinir powder for oral suspension 125 mg/5 ml, 60 ml, by Shifa Medical Products / Spimaco Misr.

• Mild to moderate community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, uncomplicated skin/skin structure infections, and (pediatric) acute bacterial otitis media caused by susceptible organisms (US cefdinir indications)DailyMed (U.S. NLM)

• In US adult/adolescent trials with cefdinir capsules, common related events included diarrhea (about 15%), vaginal moniliasis (about 4% of women), nausea (about 3%), headache (about 2%), and abdominal pain (about 1%).International label, same formulation · DailyMed (U.S. NLM)

• Cefdinir is contraindicated in patients with known allergy to the cephalosporin class of antibiotics.International label, same formulation · DailyMed (U.S. NLM)

• Before therapy, inquire about prior hypersensitivity to cefdinir, other cephalosporins, penicillins or other drugs; cross-hypersensitivity among beta-lactams may occur in up to about 10% of penicillin-allergic patients. Serious hypersensitivity may require epinephrine and emergency measures. Clostridioides difficile-associated diarrhea (CDAD) has been reported with nearly all antibacterials including cefdinir.International label, same formulation · DailyMed (U.S. NLM)

• Historical US labeling assigned Pregnancy Category B: animal studies did not show teratogenicity at studied doses; there are no adequate well-controlled studies in pregnant women; use during pregnancy only if clearly needed.General active-ingredient information · DailyMed (U.S. NLM)
• Following single 600 mg oral doses, cefdinir was not detected in human breast milk (US label).General active-ingredient information · DailyMed (U.S. NLM)

• Cefdinir: Bactericidal; inhibits bacterial cell wall synthesis like other cephalosporins; stable to some but not all beta-lactamases (US label).